Suchergebnisse - "Leporati, Rita"

PubPharm (22)

1

Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs

enthalten in: Tumori | 2024

von Leporati, R. | Miliziano, D. | Beninato, T. | +7

2

APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies : Integration of Real-World Data and Translational Research

enthalten in: Clinical lung cancer | 2024

von Prelaj, A. | Ganzinelli, M. | Provenzano, L. | +63

3

Recent advances and future strategies in first-line treatment of ES-SCLC

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Gomez-Randulfe, I. | Leporati, R. | Gupta, B. | +2

4

High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Manglaviti, S. | Bini, M. | Apollonio, G. | +24

5

Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors : the phase Ib trial MetNET2

enthalten in: Journal of hematology & oncology | 2023

von Pusceddu, S. | Corti, F. | Prinzi, N. | +25

6

Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations

enthalten in: Clinical lung cancer | 2023

von Brambilla, M. | Beninato, T. | Piemontese, A. | +24

7

Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations : Different biological and clinical entities with potentially diverse therapeutic opportunities

enthalten in: Critical reviews in oncology/hematology | 2023

von Zattarin, E. | Taglialatela, I. | Lobefaro, R. | +13

8

Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors : rationale and protocol of the phase II LOLA trial

enthalten in: BMC cancer | 2023

von Corti, F. | Brizzi, M. | Amoroso, V. | +18

9

Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial

enthalten in: BMC cancer | 2023

von Corti, F. | Brizzi, M. | Amoroso, V. | +18

10

Public and patient involvement : a survey on knowledge, experience and opinions among researchers within a precision oncology European project

enthalten in: BMC cancer | 2023

von Mosconi, P. | Colombo, C. | Paletta, P. | +105